SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Eliasson M) srt2:(2005-2009)"

Sökning: WFRF:(Eliasson M) > (2005-2009)

  • Resultat 1-50 av 67
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bunck, M. C., et al. (författare)
  • One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial
  • 2009
  • Ingår i: Diabetes Care. - 1935-5548. ; 32:5, s. 762-8
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: Traditional blood glucose-lowering agents do not sustain adequate glycemic control in most type 2 diabetic patients. Preclinical studies with exenatide have suggested sustained improvements in beta-cell function. We investigated the effects of 52 weeks of treatment with exenatide or insulin glargine followed by an off-drug period on hyperglycemic clamp-derived measures of beta-cell function, glycemic control, and body weight. RESEARCH DESIGN AND METHODS: Sixty-nine metformin-treated patients with type 2 diabetes were randomly assigned to exenatide (n = 36) or insulin glargine (n = 33). beta-Cell function was measured during an arginine-stimulated hyperglycemic clamp at week 0, at week 52, and after a 4-week off-drug period. Additional end points included effects on glycemic control, body weight, and safety. RESULTS: Treatment-induced change in combined glucose- and arginine-stimulated C-peptide secretion was 2.46-fold (95% CI 2.09-2.90, P < 0.0001) greater after a 52-week exenatide treatment compared with insulin glargine treatment. Both exenatide and insulin glargine reduced A1C similarly: -0.8 +/- 0.1 and -0.7 +/- 0.2%, respectively (P = 0.55). Exenatide reduced body weight compared with insulin glargine (difference -4.6 kg, P < 0.0001). beta-Cell function measures returned to pretreatment values in both groups after a 4-week off-drug period. A1C and body weight rose to pretreatment values 12 weeks after discontinuation of either exenatide or insulin glargine therapy. CONCLUSIONS: Exenatide significantly improves beta-cell function during 1 year of treatment compared with titrated insulin glargine. After cessation of both exenatide and insulin glargine therapy, beta-cell function and glycemic control returned to pretreatment values, suggesting that ongoing treatment is necessary to maintain the beneficial effects of either therapy.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Eliasson, A. C., et al. (författare)
  • The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability
  • 2006
  • Ingår i: Dev Med Child Neurol. - 0012-1622 .- 1469-8749. ; 48:7, s. 549-54
  • Tidskriftsartikel (refereegranskat)abstract
    • The Manual Ability Classification System (MACS) has been developed to classify how children with cerebral palsy (CP) use their hands when handling objects in daily activities. The classification is designed to reflect the child's typical manual performance, not the child's maximal capacity. It classifies the collaborative use of both hands together. Validation was based on the experience within an expert group, a review of the literature, and thorough analysis of children across a spectrum of function. Discussions continued until consensus was reached, first about the constructs, then about the content of the five levels. Parents and therapists were interviewed about the content and the description of levels. Reliability was tested between pairs of therapists for 168 children (70 females, 98 males; with hemiplegia [n=52], diplegia [n=70], tetraplegia [n=19], ataxia [n=6], dyskinesia [n=19], and unspecified CP [n=2]) between 4 and 18 years and between 25 parents and their children's therapists. The results demonstrated that MACS has good validity and reliability. The intraclass correlation coefficient between therapists was 0.97 (95% confidence interval 0.96-0.98), and between parents and therapist was 0.96 (0.89-0.98), indicating excellent agreement.
  •  
6.
  •  
7.
  • Fex, Malin, et al. (författare)
  • A beta cell-specific knockout of hormone-sensitive lipase in mice results in hyperglycaemia and disruption of exocytosis.
  • 2009
  • Ingår i: Diabetologia. - : Springer Science and Business Media LLC. - 1432-0428 .- 0012-186X. ; 52, s. 271-280
  • Tidskriftsartikel (refereegranskat)abstract
    • AIMS/HYPOTHESIS: The enzyme hormone-sensitive lipase (HSL) is produced and is active in pancreatic beta cells. Because lipids are known to play a crucial role in normal control of insulin release and in the deterioration of beta cell function, as observed in type 2 diabetes, actions of HSL in beta cells may be critical. This notion has been addressed in different lines of HSL knockout mice with contradictory results. METHODS: To resolve this, we created a transgenic mouse lacking HSL specifically in beta cells, and characterised this model with regard to glucose metabolism and insulin secretion, using both in vivo and in vitro methods. RESULTS: We found that fasting basal plasma glucose levels were significantly elevated in mice lacking HSL in beta cells. An IVGTT at 12 weeks revealed a blunting of the initial insulin response to glucose with delayed elimination of the sugar. Additionally, arginine-stimulated insulin secretion was markedly diminished in vivo. Investigation of the exocytotic response in single HSL-deficient beta cells showed an impaired response to depolarisation of the plasma membrane. Beta cell mass and islet insulin content were increased, suggesting a compensatory mechanism, by which beta cells lacking HSL strive to maintain normoglycaemia. CONCLUSIONS/INTERPRETATION: Based on these results, we suggest that HSL, which is located in close proximity of the secretory granules, may serve as provider of a lipid-derived signal essential for normal insulin secretion.
  •  
8.
  • Glimsdal, E., et al. (författare)
  • Photo-physical properties and OPL of some new longer thiophenyl-containing arylalkynyl Pt(II) compounds
  • 2007
  • Ingår i: Optical Materials in Defence Systems Technology IV. - : SPIE - International Society for Optical Engineering. - 9780819468987 ; , s. -M7400
  • Konferensbidrag (refereegranskat)abstract
    • The photo-physical and optical power limiting (OPL) properties of several new thiophenyl-containing arylalkynyl Pt(II) complexes with longer arylalkynyl groups, named ATP3, ATP4, ATP6 and ATP7 were studied. Thiophene units were introduced into the structure as an attempt to modify photo-physical properties and OPL capability. The new compounds have their thiophene rings either close to the Pt-atom (ATP7), in the middle of the chain (ATP3), or at the terminal end (ATP4). The measurement results were compared with those of the earlier studied PE3 compound. ATP6 is similar to ATP4, but with methoxy groups in the arylalkynyl ligands. Just as PE3, all thiophenyl derivatives showed large intersystem crossing capabilities and triplet phosphorescence, thus having the potential of large nonlinear absorption and good OPL performance. All compounds are characterized by absorption and emission spectra, quantum yield, luminescence decay (fluorescence and phosphorescence) and two-photon absorption capabilities at 780 nm, and compared to the properties of the PE3 compound. Also analogous triazole-containing compounds, abbreviated Z1, Z2 and Z3, were studied in the same way, and compared to the earlier studied Pt1-G1 compound. The OPL performance of all compounds were measured, and clamping levels of approximately 2.5 to 5 μJ pulse energy from 30 mM (ATP) and 50 mM (triazole) concentration samples were found. All compounds possess high transmission in the visible region and fluorescence quantum yields in the order of 10-2 (ATP) and 10-3 (triazoles).
  •  
9.
  • Haglund, B, et al. (författare)
  • Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden
  • 2007
  • Ingår i: Scandinavian journal of public health. - : SAGE Publications. - 1403-4948 .- 1651-1905. ; 35:6, s. 618-622
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The potential risks of Swedish moist snuff (snus) are debated and studies have shown diverging results. Aims: The aim of this study is to investigate whether there is any excess risk of ischaemic heart disease (IHD) and stroke from snuff use. Methods: The Swedish Survey of Living Conditions from 1988—89 was record-linked to the Swedish Cause of Death Register and the Swedish Hospital Discharge Register to investigate excess mortality and hospitalization from IHD and stroke. A Poisson regression model was used and incidence rate ratios (IRRs) for snuff and smoking were calculated controlling for age, physical activity, self-reported health, number of longstanding illnesses, residential area, and socioeconomic position. Results: Among snuff users there were no excess risks of mortality or hospitalization from IHD (IRR 0.8; 0.5—1.2,) or stroke (IRR 1.1; 0.7—1.8), but, as expected, clear excess risks were found for smokers (IRR 1.7; 1.4—2.1 for IHD, and IRR 1.4; 1.0—1.9 for stroke). Conclusions: This study has not shown any excess risk among users of snuff for IHD or stroke. If there is a risk associated with snuff it is evidently much lower than those associated with smoking.
  •  
10.
  • Iezzi, M, et al. (författare)
  • Adenovirus-mediated silencing of Synaptotagmin 9 inhibits Ca2+-dependent insulin secretion in islets
  • 2005
  • Ingår i: FEBS Letters. - : Wiley. - 1873-3468 .- 0014-5793. ; 579:23, s. 5241-5246
  • Tidskriftsartikel (refereegranskat)abstract
    • Synaptotagmins (Syts) are involved in Ca2+-dependent insulin release. However, which Syt isoform is functional in primary beta-cells remains unknown. We demonstrate by electron microscopy of pancreatic islets, the association of Syt 9 with insulin granules. Silencing of Syt 9 by RNA interference adenovirus in islet cells had no effect on the expression of Syt 5, Syt 7 and Syt 3 isoforms. The latter was localized at the plasma membrane of pancreatic polypeptide cells. Insulin release in response to glucose or tolbutamide was strongly inhibited in Syt 9 deficient islets, whereas exocytosis potentiated by raising cAMP levels, was unaltered. Thus, Syt 9 may act as Ca2+ sensor for beta-cell secretion.
  •  
11.
  • Lind, P., et al. (författare)
  • A theoretical and experimental study of non-linear absorption properties of substituted 2,5-di-(phenylethynyl)thiophenes and structurally related compounds
  • 2009
  • Ingår i: Molecular Physics. - : Informa UK Limited. - 0026-8976 .- 1362-3028. ; 107:7, s. 629-641
  • Tidskriftsartikel (refereegranskat)abstract
    • Photo-physical properties relevant for optical power limiting in the near-visible and visible regions of the spectrum are reported for a series of substituted diarylalkynyl chalcogenophenes (furans, thiophenes, selenophenes, and tellurophenes). The linear ground and excited state absorption as well as the nonlinear (two-photon) absorption were determined at the time-dependent density functional theory level with use of the hybrid exchange-correlation functionals B3LYP and CAM-B3LYP. A selected number of the theoretically studied molecules were synthesized and characterized experimentally with the use of absorption and luminescence spectroscopy. The photo-physical data are compared to the results from optical power limiting measurements performed in THF solution at a wavelength of 532 nm, with a laser pulse length of 5 ns and pulse energies up to 150 J. The best compounds in the present investigation display an energy damping by approximately a factor of 10 at a concentration of 0.010 M.
  •  
12.
  •  
13.
  • Parola, S., et al. (författare)
  • Hybrid materials for non linear absorption
  • 2005
  • Ingår i: Nonlinear Optical Transmission and Multiphoton Processes in Organics III. - : SPIE - International Society for Optical Engineering. ; , s. 1-5
  • Konferensbidrag (refereegranskat)abstract
    • Alkynyl platinum derivatives and thiacalixarenes were trapped in solid transparent matrices prepared by the sol-gel process. By using functionalyzed silicon alkoxides, molecular species were grafted to the gel matrix giving a high doping concentration and chemically stable materials. In this communication we present broadband optical limiting performance in the visible wavelength region observed in the prepared materials.
  •  
14.
  •  
15.
  • Sayed, Fatema, et al. (författare)
  • Dust ion-acoustic solitary waves in a dusty plasma with positive and negative ions
  • 2008
  • Ingår i: Physics of Plasmas. - : American Institute of Physics (AIP). - 1070-664X .- 1089-7674. ; 15:6
  • Tidskriftsartikel (populärvet., debatt m.m.)abstract
    • Properties of small but finite amplitude dust ion-acoustic (DIA) solitary waves in a dusty plasma composed of inertialess electrons, positive and negative inertial ions, and immobile negative/positive charged dust grains are investigated. By using the multifluid dusty plasma model, the Kortweg–de Vries equation and energy integral for small and large amplitude solitary pulses, are derived. It is found that the presence of the negative ions modifies the properties of the solitary DIA waves, and provides the possibility of positive and negative solitary potential structures to coexist. The present results may be useful for understanding the salient features of localized DIA excitations that may appear in data from forthcoming laboratory experiments and space observations.
  •  
16.
  •  
17.
  •  
18.
  •  
19.
  •  
20.
  •  
21.
  • Andersson, H., et al. (författare)
  • Transcriptional profiling of the peripheral blood response during tularemia
  • 2006
  • Ingår i: Genes and Immunity. - : Springer Science and Business Media LLC. - 1466-4879 .- 1476-5470. ; 7:6, s. 503-513
  • Tidskriftsartikel (refereegranskat)abstract
    • Tularemia is a febrile disease caused by the highly contagious bacterium Francisella tularensis. We undertook an analysis of the transcriptional response in peripheral blood during the course of ulceroglandular tularemia by use of Affymetrix microarrays comprising 14,500 genes. Samples were obtained from seven individuals at five occasions during 2 weeks after the first hospital visit and convalescent samples 3 months later. In total, 265 genes were differentially expressed, 95 of which at more than one time point. The differential expression was verified with real-time quantitative polymerase chain reaction for 36 genes (R(2)=0.590). The most prominent changes were noted in samples drawn on days 2-3 and a considerable proportion of the upregulated genes appeared to represent an interferon-gamma-induced response and also a proapoptotic response. Genes involved in the generation of innate and acquired immune responses were found to be downregulated, presumably a pathogen-induced event. A logistic regression analysis revealed that seven genes were good predictors of the early phase of tularemia. This is the first description of the transcriptional host response to ulceroglandular tularemia and the study has identified gene subsets relevant to the pathogenesis of the disease and subsets that may serve as early diagnostic biomarkers.
  •  
22.
  •  
23.
  •  
24.
  • Björck, M, et al. (författare)
  • Twenty years with the Swedvasc Registry.
  • 2008
  • Ingår i: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. - : Elsevier BV. - 1532-2165 .- 1078-5884. ; 35:2, s. 129-30
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
25.
  •  
26.
  • Cederholm, Jan, et al. (författare)
  • Risk prediction of cardiovascular disease in type 2 diabetes : A risk equation from the Swedish National Diabetes Register (NDR)
  • 2008
  • Ingår i: Diabetes Care. - : American Diabetes Association. - 0149-5992 .- 1935-5548. ; 31:10, s. 2038-2043
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE - Risk prediction models obtained in samples from the general population do mot perform well in type 2 diabetic patients. Recently, 5-year risk estimates were proposed as being more accurate than 10-year risk estimates. This study presents a diabetes-specific equation for estimation of the absolute 5-year risk of first incident fatal/nonfatal cardiovascular disease (CVD) in type 2 diabetic patients with the use of A1C and clinical characteristics.RESEARCH DESIGN AND METHODS - The study was based on 11,646 female and male patients, aged 18-70 years, from the Swedish National Diabetes Register with 1,482 first incident CVD events based on 58,342 person-years with mean follow-up) of 5.64 years.RESULTS - This risk equation incorporates A1C, as in the UK Prospective Diabetes Study risk engine, and several clinical characteristics: onset age of diabetes, diabetes duration, sex, BMI, smoking, systolic blood pressure, and antihypertensive and lipid-reducing drugs. All predictors included were associated with the Outcome (P < 0.0001, except for BMI P = 0.0016) with Cox regression analysis. Calibration was excellent when assessed by comparing observed and predicted risk. Discrimination was sufficient, with a receiver operator curve statistic of 0.70. Mean 5-year risk of CVD in all patients was 12.0 +/- 7.5%, whereas 54% of the patients had a 5-year risk >= 10%.CONCLUSIONS - This more simplified risk equation enables 5-year risk prediction of CVD based on easily available nonlaboratory predictors in clinical practice and A1C and was elaborated in a large observational study obtained from the normal patient population aged up to 70 years.
  •  
27.
  •  
28.
  •  
29.
  • Eeg-Olofsson, Katarina, 1968, et al. (författare)
  • Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
  • 2009
  • Ingår i: Diabetologia. - : Springer Science and Business Media LLC. - 1432-0428 .- 0012-186X. ; 52:1, s. 65-73
  • Tidskriftsartikel (refereegranskat)abstract
    • AIMS/HYPOTHESIS: The aim of this study of type 2 diabetic patients in the Swedish National Diabetes Register was to study the associations of BMI, overweight (BMI 25-29.9 kg/m(2)) and obesity (BMI >or= 30 kg/m(2)) with cardiovascular disease in type 2 diabetes, as these associations have not previously been clarified. METHODS: Patients aged 30-74 years with no previous CHD or stroke (N = 13,087) were followed for a mean of 5.6 years until 2003 for fatal or non-fatal CHD, stroke, cardiovascular disease (CHD or stroke) and total mortality. In total, 1,922 cardiovascular-disease events occurred, based on 64,864 person-years. RESULTS: The relative risks of CHD, stroke, cardiovascular disease and total mortality for a 5 unit increase in BMI at baseline were 15%, 11%, 13% and 27%, respectively, using Cox regression analysis, after adjusting for age, sex, diabetes duration, hypoglycaemic treatment and smoking (model 1), and were 9%, 4% (not significant), 7% and 20%, respectively, when adjusting also for HbA(1c), blood pressure, antihypertensive drugs, lipid-reducing drugs and microalbuminuria (model 2). Adjusted hazard ratios (model 1) for CHD, cardiovascular disease and total mortality with overweight were 1.27 (95% CI 1.09-1.48), 1.24 (1.09-1.41) and 1.16 (0.94-1.45), respectively, and 1.49 (1.27-1.76), 1.44 (1.26-1.64) and 1.71 (1.36-2.14) with obesity, as compared with normal weight. Significant hazard ratios were attenuated when adjusted according to model 2. For a 1 unit increase in BMI during follow-up, the relative risk of CHD (model 2) was 1.13 (1.04-1.23; p = 0.005). CONCLUSIONS/INTERPRETATION: Both overweight and obesity independently increased the risk of CHD and cardiovascular disease in patients with type 2 diabetes. The CHD risk was higher with increasing BMI than with stable or decreasing BMI during the study.
  •  
30.
  • Eliasson, Björn, 1959, et al. (författare)
  • Behandling med perorala antidiabetika
  • 2009
  • Ingår i: Diabetes (fjärde upplagan). - Stockholm : Liber AB. - 9789147093311 ; , s. 162-177
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
31.
  •  
32.
  •  
33.
  • Eliasson-Lappalainen, Rosmari, et al. (författare)
  • Vardagslivsforskning
  • 2008
  • Ingår i: Forskningsmetodik för socialvetare. - : Natur & Kultur, Stockholm.
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
34.
  •  
35.
  •  
36.
  • Fahlén, M, et al. (författare)
  • Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.
  • 2005
  • Ingår i: Diabetic medicine : a journal of the British Diabetic Association. - : Wiley. - 0742-3071. ; 22:4, s. 382-6
  • Tidskriftsartikel (refereegranskat)abstract
    • AIMS: To compare the effects on glycaemic control after using continuous subcutaneous insulin infusion (CSII) or insulin glargine. METHODS: Data were obtained from 17 diabetes outpatient clinics in Sweden, employing the same diabetes data management system. Type 1 diabetic patients using multiple dose injections were included prior to starting on either CSII (n = 563) or glargine (n = 513). The median duration of therapy was 25 months for CSII and 6 months for glargine. The comparison between the treatment modalities was carried out by multiple regression analysis and logistic regression analysis in an attempt at reducing the influence of confounding factors. RESULTS: The mean HbA1c decrease was 0.59 +/- 1.19% for CSII and 0.20 +/- 1.07% for glargine (P < 0.001, when assessed by logistic regression). An additional 0.1% lower HbA1c would be expected if glargine had been optimized with basal insulin 40-60% of the daily dose. The more pronounced effect of CSII was achieved with a lower daily dosage of insulin. In a multiple regression analysis with a change of HbA1c as the dependent variable, the following variables were significant: choice of treatment (P < 0.001), HbA1c prior to treatment (P < 0.001) and BMI prior to treatment (P < 0.01). CONCLUSION: Both regimes improved metabolic control, but CSII resulted in significantly higher reduction in HbA1c than after insulin glargine treatment, particularly in those individuals who had higher levels of HbA1c at baseline.
  •  
37.
  • Fugl-Meyer, K. S., et al. (författare)
  • The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress : a multicentre, non-randomised, open-label clinical study
  • 2006
  • Ingår i: International journal of clinical practice (Esher). - : Hindawi Limited. - 1368-5031 .- 1742-1241. ; 60:11, s. 1386-1393
  • Tidskriftsartikel (refereegranskat)abstract
    • A multicentre, non-randomised, open-label study assessed whether personal distress caused by erectile dysfunction (ED) affected psychosocial outcomes of tadalafil treatment. Eligible Swedish men at least 18 years old reporting >= 3-month history of ED were stratified into two groups (manifest or mild/no distress) based upon a distress question administered at enrolment. Tadalafil 20 mg was taken as needed for 8 weeks. The primary outcome was the difference between the two distress groups in change from baseline in the Psychological and Interpersonal Relationship Scales (PAIRS) spontaneity domain. Secondary outcome measures were PAIRS sexual self-confidence and time concerns domains, Life Satisfaction (LiSat-11) checklist and a Global Assessment of Treatment Response. The study also assessed tolerability. Of 662 men enrolled, 88% had manifest distress and 12% had mild/no distress. Baseline-to-endpoint changes for PAIRS domains were not significantly different between groups. Baseline-to-endpoint changes in LiSat-11 items were not significantly different between groups except for satisfaction with sexual life. Compared with men without ED, below normal baseline satisfaction with partner relationship and family life were normalised at endpoint. Over 90% of men reported improved erection and ability to engage in sexual activity. The most common treatment-emergent adverse events were headache, myalgia, dyspepsia, flushing and back pain. One man discontinued because of myalgia; 630 (95%) completed the study. In conclusion, erectile distress levels vary among patients with ED and distress can affect intra-familiar aspects of life, which may have implications for clinical practise. However, distress does not appear to hinder improvement in both mechanical and psychosocial outcomes of tadalafil treatment.
  •  
38.
  • Gledhill, Igle M. A., et al. (författare)
  • Accelerating Systems : Some Remarks on Pitch Damping
  • 2006
  • Ingår i: Proc. 5th South African Conference on Computational and Applied Mechanics. - : South African Association for Theoretical and Applied Mechanics. - 1919966013 ; , s. 268-275
  • Konferensbidrag (refereegranskat)
  •  
39.
  •  
40.
  •  
41.
  • Grönros, Julia, 1978, et al. (författare)
  • Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis
  • 2008
  • Ingår i: American Journal of Physiology-Heart and Circulatory Physiology. - : American Physiological Society. - 0363-6135 .- 1522-1539. ; 295:5
  • Tidskriftsartikel (refereegranskat)abstract
    • This study investigated the effects of rosuvastatin on plaque progression and in vivo coronary artery function in apolipoprotein E-knockout (ApoE-KO) mice, using noninvasive high-resolution ultrasound techniques. Eight-week-old male ApoE-KO mice ( n = 20) were fed a high-fat diet with or without rosuvastatin (10 μmol·kg−1·day−1) for 16 wk. When compared with control, rosuvastatin reduced total cholesterol levels ( P < 0.05) and caused significant retardation of lesion progression in the brachiocephalic artery, as visualized in vivo using an ultrasound biomicroscope ( P < 0.05). Histological analysis confirmed the reduction of brachiocephalic atherosclerosis and also revealed an increase in collagen content in the statin-treated group ( P < 0.05). Coronary volumetric flow was measured by simultaneous recording of Doppler velocity signals and left coronary artery morphology before and during adenosine infusion. The hyperemic flow in response to adenosine was significantly greater in left coronary artery following 16 wk of rosuvastatin treatment ( P < 0.001), whereas the baseline flow was similar in both groups. In conclusion, rosuvastatin reduced brachiocephalic artery atherosclerotic plaques in ApoE-KO mice. Coronary artery function assessed using recently developed in vivo ultrasound-based protocols, also improved.
  •  
42.
  •  
43.
  • Hermansson, Liselotte M., 1954-, et al. (författare)
  • Intra- and inter-rater reliability of the assessment of capacity for myoelectric control
  • 2006
  • Ingår i: Journal of Rehabilitation Medicine. - : Medical Journals Sweden AB. - 1650-1977 .- 1651-2081. ; 38:2, s. 118-23
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: To examine the reliability of the Assessment of Capacity for Myoelectric Control (ACMC) in children and adults with a myoelectric prosthetic hand.DESIGN: Intra-rater and inter-rater reliability estimated from reported assessments by 3 different raters.PATIENTS: A sample of convenience of 26 subjects (11 males, 15 females) with upper limb reduction deficiency or amputation and myoelectric prosthetic hands were video-taped during a regular clinical visit for ACMC. Participants' ages ranged from 2 to 40 years.METHODS: After instruction, 3 occupational therapists with no, 10 weeks' and 15 years' clinical experience of myoelectric prosthesis training and follow-up independently rated the 30 ACMC items for each patient. The ratings were repeated after 2-4 weeks. Inter- and intra-rater reliability in items was examined by using weighted kappa statistics and Rasch-measurement analyses.RESULTS: The mean intra-rater agreement in items was excellent (kappa 0.81) in the more experienced raters. Fit statistics showed too much variation in the least experienced rater, who also had only good (kappa 0.65) agreement in items. The stability of rater calibrations between first and second assessment showed that no rater varied beyond chance (>0.50 logit) in severity. The mean inter-rater agreement in items was fair; kappa 0.60, between the experienced raters and kappa 0.47 between raters with no and 10 weeks' experience.CONCLUSION: Overall, the agreement was higher in the more experienced raters, indicating that reliable measures of the ACMC require clinical experience from myoelectric prosthesis training.
  •  
44.
  •  
45.
  •  
46.
  • Lind, Marcus, 1976, et al. (författare)
  • The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables
  • 2009
  • Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 4:2
  • Tidskriftsartikel (refereegranskat)abstract
    • Aim The updated mean HbA1c has been used in risk estimates of diabetic complications, but it does not take into account the temporal relationship between HbA1c and diabetic complications. We studied whether the updated mean HbA1c underestimated the risk of diabetic complications. Method Continuous HbA1c curves for 10,000 hypothetical diabetes patients were simulated over an average of 7 years. Simulations were based on HbA1c values encountered in clinical practice. We assumed that each short time interval of the continuous HbA1c curves had a long-lasting effect on diabetic complications, as evidenced by earlier studies. We tested several different HbA1c variables including various profiles, e.g. different duration, of such a long-lasting effect. The predictive power of these variables was compared with that of the updated mean HbA1c. Results The predictive power of the constructed HbA1c variables differed considerably compared to that of the updated mean HbA1c. The risk increase per standard deviation could be almost 100% higher for a constructed predictor than the updated mean HbA1c. Conclusions The importance of good glycemic control in preventing diabetic complications could have been underestimated in earlier hallmark studies by not taking the time-dependent effect of HbA1c into account.
  •  
47.
  • Lundblad, Dan, et al. (författare)
  • Low level of tissue plasminogen activator activity innon-diabetic patients with a first myocardial infarction
  • 2005
  • Ingår i: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 258:1, s. 13-20
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective. To explore the role of tissue plasminogen activator (tPA) activity and plasminogen activator inhibitor type 1 (PAI-1) in survivors of a first myocardial infarction (MI). Insulin and proinsulin were analysed as potential risk factors. Design. Case-control study in northern Sweden. Subjects. A total of 115 patients under 65 years of age with a first MI were enrolled and recalled for further examination 3 months later. Twenty-seven patients were excluded, 17 with known diabetes and 10 who did not come to the follow-up, giving a final number of 88 patients, 73 men and 15 women. Patients were age- and sex matched with control subjects drawn from the local cohort in the MONICA population survey 1994. Main outcome measures. We compared MI patients and controls using univariate and multiple regression analyses including odds ratios (OR). Results. PAI-1 activity, fibrinogen, postload insulin and -proinsulin were significantly higher and tPA activity significantly lower in MI patients in the univariate analysis. In a multiple regression analysis, including also age, sex and cardiovascular risk factors, these parameters were divided in quartiles. The lowest quartile of tPA activity was significantly associated with MI (OR = 19.1; CI 3.0-123) together with the highest quartiles of fibrinogen (OR = 25; CI 5.2-120) but other variables were not. Conclusion. Low tPA activity, i.e. low fibrinolytic activity, characterized nondiabetic subjects after a first MI which is not explained by concomitant disturbances in metabolic and anthropometric variables
  •  
48.
  •  
49.
  • Mastos, M, et al. (författare)
  • Goal-directed training: linking theories of treatment to clinical practice for improved functional activities in daily life
  • 2007
  • Ingår i: Clinical rehabilitation. - : SAGE Publications. - 0269-2155 .- 1477-0873. ; 21:1, s. 47-55
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Goal-directed training is an activity-based approach to therapy. Meaningful, client-selected goals are used to provide opportunities for problem solving and to indirectly drive the movements required to successfully meet the task demands. This is in contrast to interventions that focus on changing body functions. Here, the principles of goal-directed training will be studied through two case studies with the aim of linking theories of treatment to clinical practice. Principles illustrated: The approach is based on the dynamic systems motor control theory and occupation-based therapy models, which suggest that movement patterns emerge from the interaction between the person's abilities, environment and the goal. Motor learning principles are applied to structure and schedule practice. Theory in practice: Four components provide the basis for goal-directed training: (1) selection of a meaningful goal; (2) analysis of baseline performance; (3) intervention/ practice regime; and (4) evaluation of outcome. Two individuals with acquired brain injury practised self-care tasks: eating and tying hair into a ponytail. Intensive training was undertaken over four weeks and the intervention outcome measured using the Goal Attainment Scale. Conclusions: The positive achievements in the self-care tasks illustrated that theories of motor control and motor learning can be applied to goal-directed training. The examples demonstrated that the approach could be applied to individuals with a range of abilities.
  •  
50.
  • Moslem, Waleed M., et al. (författare)
  • Three-dimensional electrostatic waves in a nonuniform quantum electron–positron magnetoplasma
  • 2008
  • Ingår i: Physics Letters A. - : Elsevier BV. - 0375-9601 .- 1873-2429. ; 372:19, s. 3471-3475
  • Tidskriftsartikel (refereegranskat)abstract
    • The dispersion properties of three-dimensional electrostatic waves in a nonuniform quantum electron–positron magnetoplasma are examined. A new dispersion relation is derived using the electron and positron densities response arising from the balance between the quantum Bohm and electrostatic forces, and from the electron and positron continuity and Poisson equations. In the local approximation regime, the dispersion relation admits both oscillatory and purely growing instabilities those depend on the quantum parameters as well as the density, velocity and magnetic field inhomogeneities.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-50 av 67
Typ av publikation
tidskriftsartikel (47)
konferensbidrag (18)
bokkapitel (2)
Typ av innehåll
refereegranskat (49)
övrigt vetenskapligt/konstnärligt (16)
populärvet., debatt m.m. (2)
Författare/redaktör
Eliasson, Björn, 195 ... (12)
Eliasson, B. (9)
Lindgren, M. (7)
Cederholm, Jan (7)
Gudbjörnsdottir, Sof ... (6)
Nilsson, P. M. (5)
visa fler...
Nilsson, Peter M (5)
Eeg-Olofsson, Katari ... (5)
Zethelius, Björn (5)
Eliasson, E (5)
Cederholm, J. (4)
Carlsson, M (4)
Eliasson, Lena (4)
Eliasson, M (4)
Gustafsson, LL (3)
Nordström, Jan (3)
Shukla, Padma Kant (3)
Eliasson, Bertil (3)
Afghahi, H (3)
Gudbjornsdottir, S. (3)
Eliasson, Mats (3)
Bertilsson, L (3)
Eriksson, A (3)
Shukla, Padma K (3)
Malmström, Eva (3)
Stenflo, Lennart (3)
Lopes, C. (3)
Renström, Erik (2)
Eriksson, M (2)
Nilsson, C (2)
Ingelman-Sundberg, M (2)
Carlsson, Marcus (2)
Eeg-Olofsson, Katari ... (2)
Arner, M. (2)
Svensson, M.K, 1965 (2)
Eliasson, Björn (2)
Beckung, Eva, 1950 (2)
Eliasson, AC (2)
Eliasson, H. (2)
Eliasson, Ann-Christ ... (2)
Eliasson, A C (2)
Smith, Ulf, 1943 (2)
Fahlen, M. (2)
Eiermann, B (2)
Henriksson, K. (2)
Marklund, Mattias (2)
Gudbjörnsdottir, Sof ... (2)
Baldwin, RM (2)
Pedersen, RS (2)
Mwinyi, J (2)
visa färre...
Lärosäte
Karolinska Institutet (24)
Göteborgs universitet (17)
Umeå universitet (16)
Uppsala universitet (10)
Lunds universitet (8)
Örebro universitet (6)
visa fler...
Kungliga Tekniska Högskolan (5)
Linköpings universitet (4)
Stockholms universitet (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (60)
Svenska (7)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (20)
Naturvetenskap (13)
Teknik (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy